JMIR Publications

ABSTRACT

Background:

Major chronic diseases such as cardiovascular disease, diabetes, and cancer impose a significant burden on people and the healthcare systems around the globe. Recently, Deep Learning (DL) has shown great potential towards the development of intelligent mobile health (mHealth) interventions for chronic diseases which could revolutionize the delivery of healthcare anytime-anywhere.

Objective:

To present a systematic review of studies which have used DL based on mHealth data for the diagnosis, prognosis, management, and treatment of major chronic diseases, and advance our understanding of the progress made in this rapidly developing field.

Methods:

We searched the bibliographic databases of Scopus and PubMed in order to identify papers with focus on the employment of DL algorithms using data captured from mobile devices (e.g., smartphones, smartwatches, and other wearable devices), and targeting cardiovascular disease, diabetes, or cancer. The identified studies were synthesized according to the target disease, the number of enrolled participants and their age, the study period, as well as the employed DL algorithm, the main DL outcome, the dataset used, the features selected, and the achieved performance.

Results:

20 studies were included in the review. 7 DL studies (35%) targeted cardiovascular disease, 9 studies (45%) targeted diabetes, and 4 studies (20%) targeted cancer. The most common DL outcome was diagnosis of patient condition for the cardiovascular disease studies, prediction of blood glucose values for studies in diabetes, and early detection of cancer. The DL algorithms employed most were convolutional neural networks and recurrent neural networks. The performance of DL was found overall to be satisfactory reaching more than 84% accuracy in the majority of the studies. Almost all studies did not provide details on the explainability of DL outcomes.

Conclusions:

The use of DL can facilitate the diagnosis, management and treatment of major chronic diseases through harnessing mHealth data. Prospective studies are now required to demonstrate the value of applied DL in real-life mHealth interventions.